山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (4): 64-67.doi: 10.6040/j.issn.1673-3770.0.2016.494

• 论著 • 上一篇    下一篇

RASSF2A基因甲基化在喉癌组织中的表达及意义

张明德1,张祖平2,于学民3,魏燕红1,袁英3   

  1. 1.聊城市东昌府人民医院耳鼻喉科, 山东 聊城 252000;
    2.聊城市人民医院耳鼻喉科, 山东 聊城 252000;
    3.山东大学齐鲁医院耳鼻咽喉头颈外科, 山东 青岛 266035
  • 收稿日期:2016-11-23 出版日期:2017-08-16 发布日期:2017-08-16
  • 通讯作者: 袁英. E-mail:yuanying1973@163.com

RASSF2A methylation in laryngeal squamous cell carcinoma.

ZHANG Mingde1, ZHANG Zuping2, YU Xuemin3, WEI Yanhong1, YUAN Ying3   

  1. 1. Department of Otolaryngology, Liaocheng Dongchangfu Peoples Hospital, Liaocheng 252000, Shangdong, China;2. Department of Otolaryngology, Liaocheng Peoples Hospital, Liaocheng 252000, Shangdong, China;3. Department of Otolaryngology &Head and Neck Surgery, Qilu Hospital of Shandong University, Qingdao 266035, Shandong, China
  • Received:2016-11-23 Online:2017-08-16 Published:2017-08-16

HTML

PDF (PC)

362

摘要： 目的 探讨抑癌基因RASSF2A表达水平及其基因异常甲基化与喉癌的关系及意义。 方法 采用RT-PCR及甲基化特异性PCR(MSP)检测50例喉癌组织(实验组)和10例癌旁正常黏膜组织(对照组)中RASSF2A基因mRNA的表达水平及其启动子甲基化状态。 结果 喉癌组织中有54%(27/50)存在RASSF2A基因启动子,而对照组正常黏膜组织中未发现RASSF2A基因甲基化现象,差异有统计学意义(χ2=9.818, P=0.002)。RASSF2A甲基化水平程度与喉癌患者临床病理特征无明显相关性。喉癌组织中RASSF2A基因mRNA的表达水平明显低于正常黏膜组织(χ2=9.818, P=0.002)。RASSF2A基因甲基化的喉癌组织中其mRNA的表达减少,反之亦然。 结论 喉癌组织中RASSF2A基因CpG岛甲基化与其基因表达缺失有关,可能参与了喉癌的发生发展过程。

关键词: 抑癌基因RASSF2A, 喉肿瘤, 甲基化

Abstract: Objective To evaluate the effects of methylation on RASSF2A expression during the development of laryngeal squamous cell carcinoma(LSCC). Methods Methylation-specific PCR was used to measure RASSF2A methylation and mRNA levels in tissues from 50 LSCCs(LSCC group)and 10 normal laryngeal tissues(control group). Results Hypermethylation was detected in the promoter region of RASSF2A in 54%(27/50)of the laryngeal cancer tissue samples but was not detected in control group tissues. The difference in hypermethylation was statistically significant(χ2=9.818, P=0.002). No significant correlations were found between the methylation levels of RASSF2A and the clinicopathological features of the patients with laryngeal cancer. The levels of RASSF2A mRNA in the LSCC group were significantly lower than those in normal mucosal tissues(χ2=9.818, P=0.002), because of methylation in RASSF2A in the laryngeal cancer tissue samples. Conclusion Epigenetic inactivation of RASSF2A through aberrant promoter methylation may play an important role during oncogenesis and the progression of LSCC.

Key words: Methylation, RASSF2A, Laryngeal squamous cell carcinoma

中图分类号: 

  • R739.65
[1] Karatzanis AD, Psychogios G, Waldfahrer F, et al. Management of locally advanced laryngeal cancer[J]. J Otolaryngol Head Neck Surg, 2014, 43(1):4.
[2] Gurbuz MK, Acikalin M, Tasar S, et al. Clinical effectiveness of thyroidectomy on the management of locally advanced laryngeal cancer[J]. Auris Nasus Larynx, 2014, 41(1):69-75.
[3] 李万举,孙敬武,别远志. Ras相关区域家族1A基因在喉癌及喉角化症组织中的表达及临床意义[J]. 听力学及言语疾病杂志,2014,22(6):616-619. LI Wanju, SUN Jingwu, BIE Yuanzhi. ImmunohistochemicaI expression and cIinicaI impIication of RASSF1A gene in laryngeaI squamous ceII carcinoma and keratosis of the larynx[J]. Journal of Audiology and Speech Pathology, 2014, 22(6):616-619.
[4] 许承弼,腾博,李长青,等. 喉鳞状细胞癌中RASSF1A基因启动子区甲基化及蛋白表达[J].吉林大学学报(医学版),2006,32(2):326-329. XU Chengbi, TENG Bo, LI Changqing, et al. Promoter methylation of RASSF1A gene in laryngeal squamous cell carcinoma and protein expression[J]. J Jilin Univ(Med Edition), 2006, 32(2):326-329.
[5] Wu Y, Zhang X, Lin L, et al. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer[J]. Asian Pac J Cancer Prev, 2014, 15(3):1171-1176.
[6] Zhang X, Ma Y, Wu Y, et al. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer[J]. J Obstet Gynaecol Res, 2014, 40(5):1375-1381.
[7] 任芳,王丹波. RASSF2基因甲基化与卵巢透明细胞癌的相关性[J]. 中国医科大学学报,2014,43(11):969-972. REN Fang, WANG Danbo. Investigation on the correlation between hypermethylation of RASSF2 and clear cell ovarian carcinoma[J]. Journal of China Medical University, 2014, 43(11):969-972.
[8] Costello JF, Plass C. Methylation matters[J]. J Med Gent, 2001, 38(5):285-303.
[9] Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation[J]. N Engl J Med, 2003, 349(21):2042-2054.
[10] Akino K, Toyota M, Suzuki H, et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer[J]. Gastroenterology, 2005, 129(1):156-169.
[11] Hesson LB, Wilson R, Morton D, et al. CpG island promoter hypermethylation of a novel Ras effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutuation[J]. Oncogene, 2005, 24(24):3987-3994.
[12] Park HW, Kang HC, Kim IJ, et al. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers[J]. Int J Cancer, 2007,120(1):7-12.
[13] Liao X, Siu MK, Chan KY, et al. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carciongenesis[J]. Int J Cancer, 2008, 123(2):296-302.
[14] Zhang Z, Sun D, Van do N, et al. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma[J]. Int J Cancer, 2007, 120(1):32-38.
[15] Zhao L, Cui Q, Lu Z, et al. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features[J]. Pancreas, 2012, 41(2):206-211.
[1] 赵锦成,石颖,张颖,贾占红,马新,张京秋,吴再军,王宇. 人头颈鳞癌细胞中CDH13的表达及其甲基化状态研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 60-63.
[2] 付玉贵,王海兰,孙德重,杨佩珍,陈彦林,陈志鹏. 保留部分环状软骨环的喉全切除术[J]. 山东大学耳鼻喉眼学报, 2017, 31(4): 73-75.
[3] 马玲国,郑朝攀,周敬淳,张博,龚桃根,张云静. CO2激光治疗声门型喉癌远期疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 98-100.
[4] 苏甜甜,张佳综述,孙臻峰审校. 多药耐药基因蛋白P-gp和ABCG2在喉癌等头颈肿瘤中的作用及相关信号通路[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 103-106.
[5] 王守玺, 刘荷珍. 声门上水平喉部分切除术中舌骨去留对误咽的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 45-47.
[6] 严羽, 朱江. 早期喉癌及喉癌前病变诊断的研究进展[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 80-85.
[7] 陈小玲, 费兵, 李贤斌, 吴昊. 靶向人喉癌HEP2细胞Trop2基因的siRNA构建及鉴定[J]. 山东大学耳鼻喉眼学报, 2015, 29(3): 51-53.
[8] 王玉红, 王倩, 陈萍, 钱晓云. 原发于喉部的非鳞状细胞癌11例并文献复习[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 83-88.
[9] 刘荷珍. 甲状软骨外膜和胸骨舌骨肌用于声门型喉癌切除喉重建临床分析[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 49-51.
[10] 田俊, 王丹丹, 皇甫辉, 王斌全, 李乐. 喉癌CT/MRI融合图像的建立及初步应用[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 52-55.
[11] 王英俊，孙彦，李薇，华辉，黄沂传，葛瑞锋，韩敏. 喉癌、喉咽癌手术相关肺血栓栓塞症的临床特点[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 51-54.
[12] 魏希建1，阴瑞兰2，郭星3. 增殖诱导配体在喉鳞状细胞癌中的表达[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 14-16.
[13] 刘昉1，赖建新1，李瑞玉1，李冠桢2. 喉癌患者外周血中Th17/Treg比率变化[J]. 山东大学耳鼻喉眼学报, 2013, 27(5): 4-7.
[14] 王晓彬1,潘新良2,卢永田1,魏明辉1,孙焕吉1，苗北平1. 早期声门区癌的手术治疗及疗效评估[J]. 山东大学耳鼻喉眼学报, 2013, 27(4): 53-58.
[15] 郭红光，李进让，孙建军. CO2激光声带切除术后复发相关因素分析[J]. 山东大学耳鼻喉眼学报, 2013, 27(1): 54-57.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发